SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $215,704 | -98.0% | 1,565 | -98.1% | 0.00% | -97.4% |
| Q4 2022 | $10,592,388 | +34.2% | 81,744 | +14.5% | 0.04% | +2.7% |
| Q3 2022 | $7,892,000 | +2110.6% | 71,400 | +1396.5% | 0.04% | +1750.0% |
| Q2 2022 | $357,000 | -72.3% | 4,771 | -71.1% | 0.00% | -50.0% |
| Q1 2022 | $1,290,000 | -56.2% | 16,519 | -48.1% | 0.00% | -60.0% |
| Q3 2021 | $2,943,000 | +113.3% | 31,819 | +79.2% | 0.01% | +100.0% |
| Q2 2021 | $1,380,000 | +80.4% | 17,756 | +73.1% | 0.01% | +66.7% |
| Q1 2021 | $765,000 | -56.2% | 10,258 | +0.2% | 0.00% | -62.5% |
| Q4 2020 | $1,745,000 | -69.3% | 10,236 | -74.7% | 0.01% | -63.6% |
| Q3 2020 | $5,676,000 | -16.6% | 40,413 | -4.8% | 0.02% | -35.3% |
| Q2 2020 | $6,807,000 | +423.6% | 42,451 | +146.0% | 0.03% | +580.0% |
| Q3 2019 | $1,300,000 | -73.0% | 17,254 | -45.6% | 0.01% | -70.6% |
| Q2 2019 | $4,816,000 | +1.6% | 31,700 | -20.3% | 0.02% | -5.6% |
| Q1 2019 | $4,742,000 | +1637.0% | 39,782 | +1491.3% | 0.02% | +1700.0% |
| Q4 2018 | $273,000 | -81.1% | 2,500 | -72.0% | 0.00% | -80.0% |
| Q3 2018 | $1,442,000 | +337.0% | 8,935 | +257.4% | 0.01% | +400.0% |
| Q2 2018 | $330,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |